Skip to main content
Erschienen in: Obesity Surgery 9/2008

01.09.2008 | Research Article

Laparoscopic Mini-Gastric Bypass (LMGB) in the Super-Super Obese: Outcomes in 16 Patients

verfasst von: Cesare Peraglie

Erschienen in: Obesity Surgery | Ausgabe 9/2008

Einloggen, um Zugang zu erhalten

Abstract

Background

The ideal management of the super-super obese patient (SSO) is unclear and controversy exists as to the choice of procedure as well as the risk for increased morbidity and mortality. I present my experience of laparoscopic mini-gastric bypass (LMGB) in 16 SSO patients with early follow-up results.

Methods

Review of a prospectively maintained database was performed. All the patients underwent LMGB by a single surgeon (CP). Data collected included demographics, operative time, length of stay, complications, and weight loss. Follow-up data was obtained at office visits in addition to periodic telephone interviews and e-mails. All office follow-up and review of correspondence from Primary Care Physicians (PCP) was managed by the operating surgeon.

Results

Sixteen patients were identified as being SSO and comprise the study group. There were 14 women and two men. Average age was 40 years (27–61). Average weight and BMI were 166 (150–193) and 62.4 (60–73), respectively. All procedures were performed laparoscopically by a single surgeon with no conversion to open. Average operative time was 78 min (41–147 min) and hospital stay was 1.2 days. Intraoperative complications included a liver laceration in one patient and an enterotomy in another. Both were managed laparoscopically. No patients required readmission to the hospital, and there were no major complications or deaths. Weight loss showed a consistent increase over the follow-up period with 2 year results of 72 KG lost or 65% EWL.

Conclusion

Laparoscopic mini-gastric bypass (MGB) is a technically simple and safe procedure in SSO patients. LMGB has the advantages of being a single stage procedure, being easily reversible and revisable in a laparoscopic procedure and does not sacrifice portions of the stomach or implant foreign materials. Weight loss appears favorable in the short term; however, information regarding long-term weight loss, durability, and safety profile in this population will require a greater number of patients and longer follow up.
Literatur
1.
Zurück zum Zitat Vivek NP, DaVee RT, Alverdy JT, et al. Duodenal switch provides superior weight loss in the super-obese (BMI ≥ 50 kg/m2) compared with gastric bypass. Ann Surg. 2006 October;244(4):611–9. Vivek NP, DaVee RT, Alverdy JT, et al. Duodenal switch provides superior weight loss in the super-obese (BMI ≥ 50 kg/m2) compared with gastric bypass. Ann Surg. 2006 October;244(4):611–9.
2.
Zurück zum Zitat Fazylov RM, Savel RH, Horovitz JH, et al. Association of super-super obesity and male gender with elevated mortality in patients undergoing the duodenal switch procedure. Obes Surg. 2005;15:618–23.PubMedCrossRef Fazylov RM, Savel RH, Horovitz JH, et al. Association of super-super obesity and male gender with elevated mortality in patients undergoing the duodenal switch procedure. Obes Surg. 2005;15:618–23.PubMedCrossRef
3.
Zurück zum Zitat Livingston EH, Huerta SA, Arthur D, et al. Male gender is a predictor of morbidity and age a predictor of mortality for patients undergoing gastric bypass surgery. Ann Surg. 2002;236:576–82.PubMedCrossRef Livingston EH, Huerta SA, Arthur D, et al. Male gender is a predictor of morbidity and age a predictor of mortality for patients undergoing gastric bypass surgery. Ann Surg. 2002;236:576–82.PubMedCrossRef
4.
Zurück zum Zitat Regan JP, Inabnet WB, Gagner M, et al. Early experience with two stage laparoscopic Roux en Y gastric bypass as an alternative in the super-super obese patient. Obes Surg. 2003;15:861–64.CrossRef Regan JP, Inabnet WB, Gagner M, et al. Early experience with two stage laparoscopic Roux en Y gastric bypass as an alternative in the super-super obese patient. Obes Surg. 2003;15:861–64.CrossRef
5.
Zurück zum Zitat Ren CJ, Patterson E, Gagner M, et al. Early results of laparoscopic biliopancreatic diversion with duodenal switch: a case series of 40 consecutive patients. Obes Surg. 2000;10:514–23.PubMedCrossRef Ren CJ, Patterson E, Gagner M, et al. Early results of laparoscopic biliopancreatic diversion with duodenal switch: a case series of 40 consecutive patients. Obes Surg. 2000;10:514–23.PubMedCrossRef
6.
Zurück zum Zitat DeMaria EJ, Schauer P, Patterson E, et al. The optimal surgical management of the super obese patient: the debate. Surg Innov. 2005;12(2):107–21.PubMedCrossRef DeMaria EJ, Schauer P, Patterson E, et al. The optimal surgical management of the super obese patient: the debate. Surg Innov. 2005;12(2):107–21.PubMedCrossRef
7.
Zurück zum Zitat Gould JC, Garren MJ, Boll V, et al. Laparoscopic gastric bypass: risks vs benefits up to two years following surgery in super super-obese patients. Surgery. 2006;140(4):524–29; discussion 529–31.PubMedCrossRef Gould JC, Garren MJ, Boll V, et al. Laparoscopic gastric bypass: risks vs benefits up to two years following surgery in super super-obese patients. Surgery. 2006;140(4):524–29; discussion 529–31.PubMedCrossRef
8.
Zurück zum Zitat Farkas DT, Vemulapalli P, Haider A, et al. Laparoscopic Roux en Y is safe and effective in patients with a BMI≥60. Obes Surg. 2005;15(4):486–93.PubMedCrossRef Farkas DT, Vemulapalli P, Haider A, et al. Laparoscopic Roux en Y is safe and effective in patients with a BMI≥60. Obes Surg. 2005;15(4):486–93.PubMedCrossRef
9.
Zurück zum Zitat Rutledge R. Continued excellent results with the mini-gastric bypass: six-year study in 2,410 patients. Obes Surg. 2005 Oct;15(9):1304–8.PubMedCrossRef Rutledge R. Continued excellent results with the mini-gastric bypass: six-year study in 2,410 patients. Obes Surg. 2005 Oct;15(9):1304–8.PubMedCrossRef
10.
Zurück zum Zitat Rutledge R. The mini-gastric bypass: experience with the first 1,274 cases. Obes Surg. 2001 Jun;11(3):276–80.PubMedCrossRef Rutledge R. The mini-gastric bypass: experience with the first 1,274 cases. Obes Surg. 2001 Jun;11(3):276–80.PubMedCrossRef
11.
Zurück zum Zitat Peraglie C. Mini-gastric bypass in a patient homozygous for factor V Leiden. Obes Surg. 2007;17:104–107PubMedCrossRef Peraglie C. Mini-gastric bypass in a patient homozygous for factor V Leiden. Obes Surg. 2007;17:104–107PubMedCrossRef
12.
Zurück zum Zitat Keidar A, Begleibter N, Chalaila A, et al. Bariatric surgey for high risk patients: first staged laparoscopic biliopancreatic diversion with duodenal switch for severe obesity. IMAJ. 2007;9:616–7.PubMed Keidar A, Begleibter N, Chalaila A, et al. Bariatric surgey for high risk patients: first staged laparoscopic biliopancreatic diversion with duodenal switch for severe obesity. IMAJ. 2007;9:616–7.PubMed
13.
Zurück zum Zitat Obrien PE, Dixon JB. Weight loss and early and late complications—the international experience. Am J Surg. 2002;184:42S–5S.CrossRef Obrien PE, Dixon JB. Weight loss and early and late complications—the international experience. Am J Surg. 2002;184:42S–5S.CrossRef
14.
Zurück zum Zitat Weiner R, Wagner D, Bockhorn H. Laparoscopic gastric banding for morbid obesity. J Laparoendosc Adv Surg Tech. 1999;9:23–30.CrossRef Weiner R, Wagner D, Bockhorn H. Laparoscopic gastric banding for morbid obesity. J Laparoendosc Adv Surg Tech. 1999;9:23–30.CrossRef
15.
Zurück zum Zitat Suter M, Calmes, JM, Paroz, A, et al. A 10 year experience with laparoscopic gastric banding for morbid obesity: high long term complication and failure rates. Obes Surg. 2006;16:829–35.PubMedCrossRef Suter M, Calmes, JM, Paroz, A, et al. A 10 year experience with laparoscopic gastric banding for morbid obesity: high long term complication and failure rates. Obes Surg. 2006;16:829–35.PubMedCrossRef
16.
Zurück zum Zitat Camerini G, Adami G, Marinari GM, et al. Thirteen years of follow-up in patients with adjustible silicone gastric banding for obesity: weight loss and constant rate of late specific complications. Obes Surg. 2004;14:1343–8.PubMedCrossRef Camerini G, Adami G, Marinari GM, et al. Thirteen years of follow-up in patients with adjustible silicone gastric banding for obesity: weight loss and constant rate of late specific complications. Obes Surg. 2004;14:1343–8.PubMedCrossRef
17.
Zurück zum Zitat Cottam D, Qureshi FD, Mattar SG, et al. Laparoscopic sleeve gastrectomy as an initial weight loss procedure for high risk patients with morbid obesity. Surg Endosc. 2006;20:859–63.PubMedCrossRef Cottam D, Qureshi FD, Mattar SG, et al. Laparoscopic sleeve gastrectomy as an initial weight loss procedure for high risk patients with morbid obesity. Surg Endosc. 2006;20:859–63.PubMedCrossRef
18.
Zurück zum Zitat Silecchia G, Boru C, Pecchia A, et al. Effectiveness of laparoscopic sleeve gastrectomy (first stage of bilio-pancreatic diversion with duodenal switch) on co-morbidities in super-obese high risk patients. Obes Surg. 2006;16:1138–44.PubMedCrossRef Silecchia G, Boru C, Pecchia A, et al. Effectiveness of laparoscopic sleeve gastrectomy (first stage of bilio-pancreatic diversion with duodenal switch) on co-morbidities in super-obese high risk patients. Obes Surg. 2006;16:1138–44.PubMedCrossRef
19.
Zurück zum Zitat Hamoi N, Anthone GJ, Kaufman HS, et al. Sleeve gastrectomy in the high risk patient. Obes Surg. 2006;16:1445–9.CrossRef Hamoi N, Anthone GJ, Kaufman HS, et al. Sleeve gastrectomy in the high risk patient. Obes Surg. 2006;16:1445–9.CrossRef
20.
Zurück zum Zitat Lalor P, Tucker ON, Szomstein S, et al. Complications after laparoscopic sleeve gastrectomy. SOARD. 2007;4(1):33–8. Lalor P, Tucker ON, Szomstein S, et al. Complications after laparoscopic sleeve gastrectomy. SOARD. 2007;4(1):33–8.
Metadaten
Titel
Laparoscopic Mini-Gastric Bypass (LMGB) in the Super-Super Obese: Outcomes in 16 Patients
verfasst von
Cesare Peraglie
Publikationsdatum
01.09.2008
Verlag
Springer-Verlag
Erschienen in
Obesity Surgery / Ausgabe 9/2008
Print ISSN: 0960-8923
Elektronische ISSN: 1708-0428
DOI
https://doi.org/10.1007/s11695-008-9574-z

Weitere Artikel der Ausgabe 9/2008

Obesity Surgery 9/2008 Zur Ausgabe

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.